PL3317672T3 - Wykorzystanie nukleosomów bezkomórkowych jako biomarkerów w próbkach kału - Google Patents

Wykorzystanie nukleosomów bezkomórkowych jako biomarkerów w próbkach kału

Info

Publication number
PL3317672T3
PL3317672T3 PL16736595T PL16736595T PL3317672T3 PL 3317672 T3 PL3317672 T3 PL 3317672T3 PL 16736595 T PL16736595 T PL 16736595T PL 16736595 T PL16736595 T PL 16736595T PL 3317672 T3 PL3317672 T3 PL 3317672T3
Authority
PL
Poland
Prior art keywords
biomarkers
cell
fecal samples
free nucleosomes
nucleosomes
Prior art date
Application number
PL16736595T
Other languages
English (en)
Inventor
Jacob MICALLEF
Marielle HERZOG
Original Assignee
Belgian Volition Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Belgian Volition Sprl filed Critical Belgian Volition Sprl
Publication of PL3317672T3 publication Critical patent/PL3317672T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL16736595T 2015-07-01 2016-07-01 Wykorzystanie nukleosomów bezkomórkowych jako biomarkerów w próbkach kału PL3317672T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1511542.1A GB201511542D0 (en) 2015-07-01 2015-07-01 Use of cell free nucleosomes as biomarkers
PCT/GB2016/051995 WO2017001864A1 (en) 2015-07-01 2016-07-01 Use of cell-free nucleosomes as biomarkers in fecal samples
EP16736595.6A EP3317672B1 (en) 2015-07-01 2016-07-01 Use of cell-free nucleosomes as biomarkers in fecal samples

Publications (1)

Publication Number Publication Date
PL3317672T3 true PL3317672T3 (pl) 2020-10-05

Family

ID=53872511

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16736595T PL3317672T3 (pl) 2015-07-01 2016-07-01 Wykorzystanie nukleosomów bezkomórkowych jako biomarkerów w próbkach kału

Country Status (8)

Country Link
US (1) US20180305759A1 (pl)
EP (1) EP3317672B1 (pl)
DK (1) DK3317672T3 (pl)
ES (1) ES2775178T3 (pl)
GB (1) GB201511542D0 (pl)
HR (1) HRP20200229T1 (pl)
PL (1) PL3317672T3 (pl)
WO (1) WO2017001864A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020210754A1 (en) 2019-04-10 2020-10-15 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Computational filtering of methylated sequence data for predictive modeling
US20230003735A1 (en) * 2019-12-02 2023-01-05 Belgian Volition Srl Use of cell free nucleosomes as biomarkers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201115095D0 (en) * 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
GB201115098D0 (en) * 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
AU2012349855B2 (en) * 2011-12-07 2017-12-07 Belgian Volition Sprl Method for detecting nucleosome adducts
GB201303575D0 (en) * 2013-02-28 2013-04-10 Singapore Volition Pte Ltd Method for detecting histone modifications in nucleosomes

Also Published As

Publication number Publication date
EP3317672B1 (en) 2019-12-11
WO2017001864A1 (en) 2017-01-05
US20180305759A1 (en) 2018-10-25
GB201511542D0 (en) 2015-08-12
DK3317672T3 (da) 2020-03-16
HRP20200229T1 (hr) 2020-11-13
ES2775178T3 (es) 2020-07-24
EP3317672A1 (en) 2018-05-09

Similar Documents

Publication Publication Date Title
PT3373003T (pt) Tira de teste de urina
SI3201361T1 (sl) Metode kvantificiranja brezcelične DNK
PT3015526T (pt) Composição à base de hidrofluoroolefina e sua utilização
HK1223969A1 (zh) 試劑盒及其用途
HK1231555A1 (zh) 生物標誌物及其用途
HK1255151A1 (zh) 痰液樣本中無細胞的核小體作為生物標記的用途
HK1251877A1 (zh) 生物標記和預測方法
GB201518379D0 (en) Analytical method and composition
SG11201602291TA (en) Nucleic acid biomarker and use thereof
EP3121291A4 (en) Probe reagent and fish using probe reagent
GB201514381D0 (en) Kit and Method
GB201413857D0 (en) Water sample analysis kit
SG11201604702YA (en) Biomakers of de novo lipogenesis and methods using the same
HK1250778A1 (zh) 分析物檢測及其方法
GB2523639B (en) Modified measuring cuvette
HK1257123A1 (zh) 新型mirna生物標誌物及其用途
GB201720851D0 (en) Device and methods to detect biomarkers using ologonucleotides
IL251605B (en) Use of protein in predicting intra-corporeal phenomena
PL3317672T3 (pl) Wykorzystanie nukleosomów bezkomórkowych jako biomarkerów w próbkach kału
GB2536202B (en) Cache dormant indication
BR112017013928A2 (pt) composição alimentar e método de uso.
GB201308639D0 (en) Biomarkers and uses of thereof
GB201313529D0 (en) Urine sample kit and its relative methods of use
AU2014904616A0 (en) Biomarkers and uses thereof
GB201414913D0 (en) Determination and analysis of biomarkers in clinical samples